A little over two decades ago, addressing Nigeria's HIV crisis topped U.S. President George W. Bush's priorities. Africa's ...

Gilead Sciences’ long-acting drug to block HIV has the potential to end the AIDS epidemic worldwide. But accessibility ...

There are several ways to address HIV in homeless populations, with the most promising being the low barrier care model, ...

GENEVA, 19 May 2025— As funding cuts threaten to cause an additional 6 million new HIV infections and 4 million preventable AIDS-related deaths, UNAIDS is calling on governments and partners attending ...

This makes Lenacapavir significantly more ... Sub-Saharan Africa Leads Global HIV Decline Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS ...

Announcing a new publication for Acta Materia Medica journal. The HIV-1 capsid protein (CA) plays a crucial role in viral ...

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

South Africa made massive progress in reducing transmission of HIV from mothers to their babies. Even so, about 7 000 babies still contract the virus every year. Experts put this down to having the ...

South Africa made massive progress in reducing transmission of HIV from mothers to their babies. Even so, about 7,000 babies still contract the virus every year. Experts put this down to having the ...